Gladius Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3,425
Closed -$282K – 175
2024
Q3
$282K Sell
3,425
-71
-2% -$5.3K 0.03% 102
2024
Q2
$245K Buy
+3,496
New +$250K 0.03% 126
2023
Q2
– Sell
-4,119
Closed -$239K – 428
2023
Q1
$239K Buy
4,119
+153
+4% +$10.3K 0.01% 151
2022
Q4
$287K Sell
3,966
-242
-6% -$17.3K 0.02% 123
2022
Q3
$256K Sell
4,208
-65,429
-94% -$4.18M 0.01% 142
2022
Q2
$4.37M Buy
69,637
+63,089
+963% +$4.18M 0.23% 49
2022
Q1
$461K Buy
+6,548
New +$443K 0.03% 110

Other funds holding MET

Gladius Capital Management's MET Position: Q4 2024 in Review

Gladius Capital Management sold out of MetLife (MET) in Q4 2024, closing a stake of 3,425 shares — an estimated $282K sold.

Gladius Capital Management first reported a position in MET in Q1 2022 and held it in 7 quarters. The position peaked at $4.37M in Q2 2022. 1,406 funds tracked by Wall St. Rank hold MET as of Q4 2024.

  • Gladius Capital Management reported no remaining MetLife position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 3,425 MetLife shares in Q4 2024, an estimated $282K.
  • Gladius Capital Management first reported a position in MetLife in Q1 2022 and held it in 7 quarters.
  • Gladius Capital Management's MetLife position peaked at $4.37M in Q2 2022.
  • 1,406 funds tracked by Wall St. Rank held MetLife as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.